Remove 2025 Remove Documentation Remove HIPAA
article thumbnail

Patient Consent in RPM: A Non-Negotiable Compliance Step for US Healthcare in 2025

PharmD Live

But in 2025, RPM patient consent compliance is more than a billing formality; it is a legal, regulatory, and ethical imperative. Regulatory Requirements: CMS and Medicare Consent Guidelines The Centers for Medicare & Medicaid Services (CMS) explicitly require documented patient consent before initiating RPM services.

HIPAA 52
article thumbnail

Top 10 RPM Vendors 2025: Driving Results in Remote Patient Monitoring

PharmD Live

This 2025 vendor landscape review highlights how PharmD Live stands out by combining pharmacist-led clinical expertise, AI-powered insights, and fully CMS-aligned virtual care services, delivering tangible, reportable results across complex patient populations. We show you the why and what to do about it before the patient deteriorates.

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Hidden Risks in RPM Billing: What Every US Healthcare Practice Should Know in 2025

PharmD Live

By 2025, over 71 million Americans (26% of the population) are expected to use RPM services, with the US market projected to double to $29+ billion by 2030. Operational Strain: The 2025 Medicare Physician Fee Schedule slashes reimbursement rates by 2.83%, intensifying the need for efficient, compliant RPM workflows to protect margins 3.

article thumbnail

What is Data-Driven Marketing in Pharma

Pharma Marketing Network

Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. But in 2025, it’s about personalization at scale. Data is no longer a byproduct of campaignsits the foundation.

HIPAA 59
article thumbnail

How Is AI Changing Pharma Marketing: What Brand Teams Need to Know

Pharma Marketing Network

But in 2025, the AI is Changing Pharma Marketing. In 2025, brand managers who cant interpret or apply AI-driven insights risk falling behind. Therefore, marketers must prioritize transparency, document algorithms decision-making logic, and maintain robust audit trails. While the U.S. It can be, if governed properly.

HIPAA 52
article thumbnail

Health Data Management: Everything You Need to Know

Viseven

According to the Deloitte report , the volume of health data rose by 40% between 2010 and 2020 and is predicted to climb even higher by 23% by 2025. Our solutions comply with GDPR, HIPAA, and numerous other industry standards. Pharma companies deal with enormous amounts of health data.

article thumbnail

Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution

FDA Law Blog: Biosimilars

The gray box at the top of the document at this link shows the change in position. The political battle went into gear on January 28, 2025, with an Executive Order titled Protecting Children from Chemical and Surgical Mutilation. The EO and DOJ memo were followed by a May 1, 2025 announcement of a report from the U.S.